中国CMS签署了为期15年的协议，销售Pharmacosmos IV铁药。 China's CMS signs 15-year deal to sell Pharmacosmos IV iron drugs.

华医疗系统控股有限公司与 Pharmacosmos A/S签署了一项为期15年的独家协议, 在中国大陆销售静脉注射铁制品 Monofer®和 Cosmofer®. China Medical System Holdings Limited has signed a 15-year exclusive agreement with Pharmacosmos A/S to market intravenous iron products Monofer® and Cosmofer® in mainland China. 这两种已批准的疗法都在国家补偿药物清单上,Monofer®提供高剂量选择,Cosmofer®是长期使用的治疗方法. Both approved therapies are on the National Reimbursement Drug List, with Monofer® offering a high-dose option and Cosmofer® being a long-standing treatment. 这项交易加强了CMS在贫血治疗方面的投资组合. This deal strengthens CMS's portfolio in anemia care.